These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 8252602)

  • 21. Influence of alpha-adrenergic blockade on platelet-mediated thrombosis in stenosed canine coronary arteries.
    Bolli R; Brandon TA; Mace ML; Weibaecher DG
    Cardiovasc Res; 1985 Mar; 19(3):146-54. PubMed ID: 2859114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury.
    Eidt JF; Allison P; Noble S; Ashton J; Golino P; McNatt J; Buja LM; Willerson JT
    J Clin Invest; 1989 Jul; 84(1):18-27. PubMed ID: 2661588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclical coronary flow reductions in conscious dogs equipped with ameroid constrictors to produce severe coronary narrowing.
    Gallagher KP; Osakada G; Kemper WS; Ross J
    Basic Res Cardiol; 1985; 80(1):100-6. PubMed ID: 3985922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of molsidomine on thrombus formation in stenosed coronary arteries of dogs and pigs.
    Just M; Martorana PA
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S129-36. PubMed ID: 2484691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition by the combined Ca2+ and 5-HT2 receptor antagonist nexopamil (LU 49938) of intracoronary thrombus formation in a canine model of arterial stenosis and intimal damage.
    Kirchengast M; Rübsamen K; Lehmann HD
    J Cardiovasc Pharmacol; 1993 Nov; 22(5):687-94. PubMed ID: 7506319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dispersion of coronary artery thrombi by antagonism of platelet serotonin receptor in the dog.
    Belcher PR; Drake-Holland AJ; Hynd J; Noble MI
    Cardiovasc Res; 1992 Mar; 26(3):292-6. PubMed ID: 1423425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antithrombotic actions of the thrombin inhibitor, argatroban, in a canine model of coronary cyclic flow: comparison with heparin.
    Duval N; Lunven C; O'Brien DP; Grosset A; O'Connor SE; Berry CN
    Br J Pharmacol; 1996 Jun; 118(3):727-33. PubMed ID: 8762100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxygen radical scavenging agents as adjuvant therapy with tissue plasminogen activator in a canine model of coronary thrombolysis.
    Przyklenk K; Kloner RA
    Cardiovasc Res; 1993 Jun; 27(6):925-34. PubMed ID: 8221780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preclinical considerations and results with the combination of verapamil and trandolapril: blood pressure reduction and beyond.
    Kirchengast M
    J Hypertens Suppl; 1997 Mar; 15(2):S27-33. PubMed ID: 9218195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attenuation of reactive hyperemia caused by aspirin in canine coronary artery.
    Miyajima S; Aizawa Y; Shibata A
    Angiology; 1989 Sep; 40(9):824-9. PubMed ID: 2504081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cumulative doses of NG-nitro-L-arginine methyl ester on coronary blood flow of anesthetized and conscious dogs.
    Matsunaga T; Okumura K; Ishizaka H; Tsunoda R; Yasue H
    Arch Int Pharmacodyn Ther; 1994; 327(3):251-65. PubMed ID: 7848010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treadmill exercise promotes cyclic alterations in coronary blood flow in dogs with coronary artery stenoses and endothelial injury.
    Eidt JF; Ashton J; Golino P; McNatt J; Buja LM; Willerson JT
    J Clin Invest; 1989 Aug; 84(2):517-27. PubMed ID: 2760199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries.
    Ashton JH; Benedict CR; Fitzgerald C; Raheja S; Taylor A; Campbell WB; Buja LM; Willerson JT
    Circulation; 1986 Mar; 73(3):572-8. PubMed ID: 2936531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced coronary vasoconstrictor responses to 5-hydroxytryptamine in the presence of a coronary artery stenosis in anaesthetized dogs.
    Woodman OL
    Br J Pharmacol; 1990 May; 100(1):153-7. PubMed ID: 2372656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of Z13752A, a combined ACE/NEP inhibitor, on responses to coronary artery occlusion; a primary protective role for bradykinin.
    Rastegar MA; Marchini F; Morazzoni G; Vegh A; Papp JG; Parratt JR
    Br J Pharmacol; 2000 Feb; 129(4):671-80. PubMed ID: 10683191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extracardiac to coronary anastomoses support regional left ventricular function in dogs.
    Unger EF; Shou M; Sheffield CD; Hodge E; Jaye M; Epstein SE
    Am J Physiol; 1993 May; 264(5 Pt 2):H1567-74. PubMed ID: 7684575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of the combination of anticoagulant and thromboxane synthetase inhibitor (Y-20811) or receptor blockade (S-1452) on preventing thrombotic cyclic coronary flow reduction in dogs with coronary stenosis.
    Fujii T; Matsuzaki M; Oda T; Sakai H; Tanaka N; Yano M; Miura T; Kohno M; Katayama K; Kusukawa R
    Jpn Circ J; 1992 Nov; 56(11):1191-7. PubMed ID: 1453545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of cyclic flow reduction in the coronary, carotid, and femoral arteries of conscious, chronically instrumented dogs. A model for investigating the role of platelets in severely constricted arteries.
    Al-Wathiqui MH; Hartman JC; Brooks HL; Warltier DC
    J Pharmacol Methods; 1988 Aug; 20(1):85-92. PubMed ID: 3411977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of KB-944, a novel calcium antagonist, in several models of canine myocardial ischemia.
    Pelc LR; Gross GJ; Warltier DC
    J Pharmacol Exp Ther; 1986 Jul; 238(1):113-8. PubMed ID: 3723394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of the serotonin antagonists, cyproheptadine, ketanserin and mianserin, on cyclic flow reductions in stenosed canine coronary arteries.
    Bush LR
    J Pharmacol Exp Ther; 1987 Feb; 240(2):674-82. PubMed ID: 3806419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.